C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) C12N 15/12 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2751688
The present invention provides methods for determining a prognosis of disease free or overall survival in a patient suffering from cancer. The methods generally involve determining a normalized expression level of an EMX2 gene product, which correlates with prognosis and likelihood of survival.
La présente invention concerne des procédés de détermination d'un pronostic d'absence de maladie ou de survie globale chez un patient souffrant d'un cancer. Les procédés impliquent de manière générale la détermination d'un niveau d'expression normalisée d'un produit de gène EMX2, qui est corrélé avec le pronostic et la probabilité de survie.
He Biao
Jablons David M.
Smart & Biggar
The Regents Of The University Of California
LandOfFree
Emx2 in cancer diagnosis and prognosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Emx2 in cancer diagnosis and prognosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Emx2 in cancer diagnosis and prognosis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1352590